title: Mycobacterium arupense as an Emerging Cause of Tenosynovitis.
authors.forename: Fiorella Krapp
authors.initials: FK
authors.lastname: Lopez
authors.forename: Madeline
authors.initials: M
authors.lastname: Miley
authors.forename: Babafemi
authors.initials: B
authors.lastname: Taiwo
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D006801:Humans; D016867:Immunocompromised Host; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification; D012867:Skin / Q000382:microbiology / Q000473:pathology; D013717:Tenosynovitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053583:Interleukin-1beta; C541220:canakinumab
keywords: Mycobacterium arupense; bacteria; canakinumab; corticosteroids; nontuberculous Mycobacterium infections; tenosynovitis; tuberculosis and other mycobacteria